{
    "clinical_study": {
        "@rank": "284",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 09, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04335162"
        },
        "id_info": {
            "org_study_id": "20reamedcovid19",
            "nct_id": "NCT04335162"
        },
        "brief_title": "Cardiovascular Complications and COVID-19 (CovCardioVasc)",
        "acronym": "CovCardioVasc",
        "official_title": "Screening of Cardiovascular Complications in Patients With COVID-19",
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Nice",
                "agency_class": "Other"
            }
        },
        "source": "Centre Hospitalier Universitaire de Nice",
        "oversight_info": {
            "has_dmc": "No",
            "is_fda_regulated_drug": "No",
            "is_fda_regulated_device": "No"
        },
        "brief_summary": {
            "textblock": "Patients with COVID-19 in the Intensive Care Unit (ICU) or hospitalized with severe form have\n      a poor prognosis (almost 30% rate of death). They present often a high cardiovascular risk\n      profile (almost 30% of hypertension and 19% of diabetes). Troponin has been described to be\n      elevated in a high proportion of patients (one fifth of all patients and 50% of\n      non-survivors) suggesting the possibility of cardiomyopathies. High levels of DDimers (81% of\n      non survivors) and fibrin degradation products are also associated with increased risk of\n      mortality suggesting also the possibility of venous thromboembolism. Therefore, screening for\n      cardiomyopathies and venous thromboembolism could represent an important challenge for\n      patients with COID-19 management."
        },
        "overall_status": "Recruiting",
        "start_date": {
            "@type": "Actual",
            "#text": "February 28, 2020"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "August 28, 2020"
        },
        "primary_completion_date": {
            "@type": "Anticipated",
            "#text": "August 28, 2020"
        },
        "study_type": "Observational",
        "has_expanded_access": "No",
        "study_design_info": {
            "observational_model": "Cohort",
            "time_perspective": "Prospective"
        },
        "primary_outcome": {
            "measure": "Determine the incidence of cardiomyopathies and venous thromboembolism",
            "time_frame": "28 days",
            "description": "Incidence of cardiomyopathies and/or venous thromboembolism at day 28"
        },
        "secondary_outcome": [
            {
                "measure": "Mortality",
                "time_frame": "28 days",
                "description": "Incidence of mortality at day 28"
            },
            {
                "measure": "Duration of mechanical ventilation",
                "time_frame": "28 days",
                "description": "Number of day of using mechanical ventilation for each patients"
            },
            {
                "measure": "shock at day 28",
                "time_frame": "28 days",
                "description": "Incidence of shock at day 28"
            },
            {
                "measure": "length of stay in the intensive care unit",
                "time_frame": "28 days",
                "description": "Number of day in intensive care unit"
            }
        ],
        "number_of_groups": "2",
        "enrollment": {
            "@type": "Anticipated",
            "#text": "100"
        },
        "condition": [
            "COVID",
            "Acute Coronary Syndrome",
            "Myocardial Infarction",
            "Myocarditis",
            "Venous Thromboembolism",
            "Deep Vein Thrombosis",
            "Pulmonary Embolism"
        ],
        "arm_group": [
            {
                "arm_group_label": "Intensive care unit patients",
                "description": "Patients with COVID-19 hospitalized in an intensive care unit"
            },
            {
                "arm_group_label": "Non intensive care unit patients",
                "description": "Patients with COVID-19 hospitalized who are not in an intensive care unit"
            }
        ],
        "biospec_retention": "Samples Without DNA",
        "biospec_descr": {
            "textblock": "whole blood"
        },
        "eligibility": {
            "study_pop": {
                "textblock": "Intensive Care Unit, Conventionnal"
            },
            "sampling_method": "Non-Probability Sample",
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - All consecutive patients with COVID-19 infection admitted to the ICU or hospitalized\n        because of severe form (eg: hypoxia, orthopnea, pneumonitis, kidney insufficiency) will be\n        included\n\n        Exclusion Criteria:\n\n        - Patients under 18 years"
            },
            "gender": "All",
            "minimum_age": "18 Years",
            "maximum_age": "N/A"
        },
        "overall_official": {
            "last_name": "Denis DOYEN",
            "role": "Principal Investigator",
            "affiliation": "CHU de NICE - Archet 1"
        },
        "overall_contact": {
            "last_name": "Denis DOYEN",
            "phone": "0033492035510",
            "email": "doyen.d@chu-nice.fr"
        },
        "location": [
            {
                "facility": {
                    "name": "CHU de Nice",
                    "address": {
                        "city": "Nice",
                        "zip": "06200",
                        "country": "France"
                    }
                },
                "status": "Recruiting",
                "contact": {
                    "last_name": "Denis DOYEN",
                    "phone": "0033492035510,",
                    "email": "doyen.d@chu-nice.fr"
                }
            },
            {
                "facility": {
                    "name": "H\u00f4pitaux Universitaires Paris Centre - H\u00f4pital Cochin",
                    "address": {
                        "city": "Paris",
                        "zip": "75014",
                        "country": "France"
                    }
                },
                "status": "Not yet recruiting",
                "contact": {
                    "last_name": "Mathieu Jozwiak",
                    "phone": "0033158412661",
                    "email": "mathieu.jozwiak@aphp.fr"
                }
            }
        ],
        "location_countries": {
            "country": "France"
        },
        "verification_date": "April 2020",
        "study_first_submitted": "April 3, 2020",
        "study_first_submitted_qc": "April 3, 2020",
        "study_first_posted": {
            "@type": "Actual",
            "#text": "April 6, 2020"
        },
        "last_update_submitted": "April 3, 2020",
        "last_update_submitted_qc": "April 3, 2020",
        "last_update_posted": {
            "@type": "Actual",
            "#text": "April 6, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        },
        "condition_browse": {
            "mesh_term": [
                "Pulmonary Embolism",
                "Myocardial Infarction",
                "Thrombosis",
                "Acute Coronary Syndrome",
                "Thromboembolism",
                "Embolism",
                "Venous Thromboembolism",
                "Venous Thrombosis",
                "Myocarditis"
            ]
        },
        "patient_data": {
            "sharing_ipd": "No",
            "ipd_description": "no data sharing plan has been established."
        }
    }
}